Total bids
6
6 including cancelled tenders
Awarded
4
0 lost · 0 still pending
Awarded value
₹5
of ₹1.8 L bid — 0.0% conversion
Win rate
66.7%
of 6 decided bids
Bid outcomes
How their decided bids ended, by number and by valueBy count6 bids
66.7%
33.3%
Awarded466.7%
Pending00.0%
Tech rejected233.3%
Lost00.0%
By value₹1.8 L
100.0%
Awarded₹50.0%
Pending₹00.0%
Tech rejected₹1.8 L100.0%
Lost₹00.0%
Where they win
3 authorities · 0 statesTop buyer organisations
Operating states
LowHigh
4 awards on central/PSU portals carry no state
Top competitors
In tenders they both bid · bar shows how the awards splitRival awardedDSS Takara awardedOthers
Recent tenders awarded to DSS Takara
- Tender for Annual Rate Contract of Consumables and NGS Services at NIPGRNational Institute of Plant Genome Research · 30 Jun 2026₹5
- RATE CONTRACT FOR SUPPLY OF CHEMICALS AND LABORATORY CONSUMABLES FOR THE PERIOD FROM 01 OCT 2023 TO 30 SEP 2024Indian Institute of Science Education and Research - Thiruvananthapuram · 27 Oct 2023₹0
- RATE CONTRACT FOR SUPPLY OF CHEMICALS AND LABORATORY CONSUMABLES FOR THE PERIOD FROM 01 OCT 2022 TO 30 SEP 2023Indian Institute of Science Education and Research - Thiruvananthapuram · 12 Oct 2022₹0
- ARC for Purchase of ChemicalsDepartment of Agricultural Research and Education · 3 Oct 2022₹0
About DSS Takara Bio India Pvt. Ltd
DSS Takara Bio India Pvt. Ltd appears as a bidder on 6 government tenders on record, from 5 buyer authorities in 1 state. Of its 6 decided bids, it was awarded 4 — a 66.7% win rate — worth ₹5 in total. Its most recent award on record is from 30 Jun 2026.
Its largest buyer by awarded value is National Institute of Plant Genome Research, at 100.0% of what it has won, out of 3 authorities that have awarded it work. On priced bids, its median quote is the lowest (L1).
It most often bids against Central Drug House (P) Ltd., Axiva Sichem Biotech and Genaxy Scientific Pvt. Ltd.. Central Drug House (P) Ltd. bid on 4 of the same tenders and won 4 of them; DSS Takara Bio India Pvt. Ltd won 3.